| Literature DB >> 27774447 |
Abstract
Enzymes catalyze various biochemical functions with high efficiency and specificity. In vitro design of the enzyme leads to novel bioactivity in this natural biomolecule that give answers of some vital questions like crucial residues in binding with substrate, molecular evolution, cofactor specificity etc. Enzyme engineering technology involves directed evolution, rational designing, semi-rational designing, and structure-based designing using chemical modifications. Similarly, combined computational and in vitro evolution approaches together help in artificial designing of novel bioactivity in the natural enzyme. DNA shuffling, error prone PCR and staggered extension process are used to artificially redesign active site of enzyme, which can alter its efficiency and specificity. Modifications of the enzyme can lead to the discovery of new path of molecular evolution, designing of efficient enzymes, locating active sites and crucial residues, shift in substrate, and cofactor specificity. The methods and thermodynamics of in vitro designing of the enzyme are also discussed. Similarly, engineered thermophilic and psychrophilic enzymes attain substrate specificity and activity of mesophilic enzymes that may also be beneficial for industry and therapeutics.Entities:
Keywords: in vitro design; molecular evolution; novel bioactivity of natural enzyme; strategic manipulation; thermodynamics of in vitro design
Year: 2016 PMID: 27774447 PMCID: PMC5054688 DOI: 10.3389/fchem.2016.00039
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Summary of enzyme engineering methods and their significances.
Enzymes and their mutants formed by site directed mutagenesis.
| 1. | Lactate dehydrogenase | Lactate etc. | Malate dehydrogenase | Malate etc. | Leu91Arg | Wu et al., | |
| 2. | Tyrosine phenol lyase | β- elimination of tyrosine | Dicarboxylic amino acid β-lyase enzyme | Reversible transfer of an amino group from dicarboxylic amino acids to oxo acids | Arg100Thr, Val283Arg | Mouratou et al., | |
| 3. | Tyrosine phenol lyase | β- elimination of tyrosine | Tyrosine phenol lyase | Decreased affinity for β- elimination of tyrosine | Asn185Ala, Tyr71Phe, Thr124Asp, Phe448His | Chen H. Y. et al., | |
| 4. | NAD-dependent D-lactate dehydrogenase | Pyruvate | D-2hydroxyisocaproate dehydrogenase | Larger aliphatic or aromatic 2-ketoacid substrates | Tyr52Leu | Tokuda et al., | |
| 5. | Choline acetyl transferase | Acetyl group acceptor is choline | Carnitine acetyl transferase | Specificity More for carnitine and less for choline | Val459Thr, Asp460Glu, Asn461Thr Asn514Arg | Reznik et al., | |
| 6. | Aspartate amino- transferase | reversible transfer of the amino group of aspartate or glutamate to the cognate oxo acids | L-aspartate-β decarboxylase | β-caboxylase activity | Tyr225Arg, Arg292Lys Arg386Ala | Graber et al., | |
| 7. | Lactate dehydrogenase | specific for cofactor NAD+ | Same | Utilized NADP+ far better | Phe16Gln, Cys81Ser Asn85Arg | Flores and Ellington, | |
| 8. | β-Glucuronidase | β- galactosidase activity | Same | Increased in β galactosidase activity | Thr509Ala, Ser557Pro, Asn566Ser Lys568Gln | Geddie and Matsumura, | |
| 9. | Malate dehydrogenase | Inter-conversion of malate & oxaloacetate | Same | Catalytic activity is decreased & specificity for other substrate increased | Arg153Cys | Wright and Viola, | |
| 10. | Aspartate amino transferases | Aspartate | Same | Five-fold increase in activity | Asn34Asp, Ile37Met, Ser139Gly, Asn142Thr, Asn297Ser, Val387Leu | Yano et al., | |
| 11. | Aspartate amino transferases | Aspartate | same | Valine | 17 mutations | Oue et al., | |
| 12. | Streptavidin | Biotin | Same | Biotin analogs e.g., Iminobiotin | Asn23Ala Ser27Asp | Reznik et al., | |
| 13. | 1,2 propanediol oxidoreductase | Coenzyme-NADH | Same | Coenzyme-NADH and NADPH | Asp41Ala, Asp41Gly | Ma et al., | |
| 14. | Subtilisins | Proteolytic activity | Same | Increased proteolytic activity | Lys27Arg/ Asn87Ser/ Val104Tyr/ Asn123Ser /Thr274Ala Asn76Asp/ Asn87Ser/ Ser103Ala/ Val104Ile | Graycar et al., | |
| 15. | Cholestrol oxidase | Pregnenolone, cholesterol | Same | Increased catalytic activity | Ser379Thr | Toyama et al., | |
| 16. | Isocitrate dehydrogenase | Coenzyme-NADP | Same | Coenzyme-NAD | 6 mutations | Chen R. et al., | |
| 17. | Glutamate dehydrogenase | Coenzyme-NADH | Same | Coenzyme-NADPH | Glu243Lys/Glu243Asp | Carrigan and Engel, | |
| 18. | Formate dehydrogenase | Coenzyme-NAD+ | Same | Coenzyme-NADP+ | Asp195Gln/Tyr196His | Andreadeli et al., | |
| 19. | Malate dehydrogenase | Oxaloacetate | Phenylactate dehydrogenase | Phenyl pyruvate | Arg81Cys | Wright et al., | |
| 20. | Malate dehydrogenase | NADP | same | NADPH | Glu42Gly, Ile43Ser, Pro45Arg, Ala46Ser | Ge et al., | |
| 21. | Glutaryl-7-ACA acylase | CephC | CephalosporinCacylases (CA) | CephC | His57Ser His70Ser, Leu154Tyr | Conti et al., | |
| 22. | Xylose reductase | NADPH | Same | NADH | Lys274Arg–Asn276Asp | Petschacher et al., | |
| 23. | Lactate dehydrogenase | NADH | Same | NADPH | 7 amino acid residues | Tomita et al., | |
| 24. | Xylose reductase | NADPH | Same | NADH | Lys21Ala/ Asn272Asp | Zeng et al., | |
| 25. | Glutamate dehydrogenase | NADH | Same | NADPH | Asp263Lys, Phe238Ser, Pro262Ser | Griffin and Engel, | |
| 26. | Malate dehydrogenase | NADH | Same | NADPH | 7 amino acids residues | Nishiyama et al., | |
| 27. | Lactaldehyde dehydrogenase | NADH | Same | NADPH | Phe180Thr | Rodríguez-Zavala, | |
| 28. | Carbonyl reductase | NADPH | Same | NADH | 8 amino acid residues | Morikawa et al., | |
| 29. | Nitrate reductase | NADPH | Same | NADH | Ser920Asp Arg932 Asp | Shiraishi et al., | |
| 30. | Lactate dehydrogenase | NADH | Same | NADPH | Asp175Ala | Bernard et al., | |
| 31. | Cutinase | Hydrolysis of esters and triglycerides | Same | Catalytically inactive | His204Asn | Nyon et al., | |
| 32. | Lipase | Ester synthesis and inter-esterification reaction and lipid hydrolysis | Same | Increased organic solvent stability | Ser155Leu Gly157Arg, Ser164Lys, Ser194Arg, Asp209Asn | Kawata and Ogino, | |
| 33. | Lactonase | 3-oxo-N-dodecanoyl-L-homoserine lactone | Same | 72-fold increase in the catalytic efficiency | Glu101Asn/ Arg230Ile | Chow et al., | |
| 3-oxo-N-dodecanoyl-L-homoserine lactone | Same | Asp266Asn | Chow et al., | ||||
| 34. | alkalophilic Bacillus sp. | Cyclodextrin glucano transferase | produce cyclodextrins from starch | Same | higher product yields | His233Tyr | Leemhuis et al., |
| 35. | Lactaldehyde reductase | NADH | Same | 3.6-fold increase in kcat | Met185Cys | Cahn et al., | |
| 36. | Cinnamyl alcohol dehydrogenase | NAD(P)H | Same | 82-fold increase in activity | Gln110Val | Cahn et al., | |
| 37. | Cephalosporin acyclase | Cephalosporin | Same | Phe177(β)Gly/Met145(α)Ala and Phe177(β)Gly/Met145(α)Ala/Tyr149(α)Val | Isogai and Nakayama, |